OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $185.4 million versus the consensus estimate of $168.21 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.